Otsuka Pharmaceutical Co., Ltd. et al v. MSN Laboratories Private, Ltd. et al > Summary
Court Case Number 1:19-cv-02009
Filing Date Oct 23, 2019
Termination Date Oct 14, 2022
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesLeonard P. Stark
Plaintiff Attorneys
21Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Douglas W. Cheek
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Eric J. Fues
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Douglas W. Cheek
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Eric J. Fues
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Collette Corser
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Tyler B. Latcham
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Denise Main
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: James B. Monroe
Finnegan, Henderson, Farabow, Garrett & Dunner
Otsuka Pharmaceutical
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
H. Lundbeck A/S
Attorney Name: Erin McGeehan Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner
Attorney Name: Douglas W. Cheek
Attorney Name: Collette Corser
Attorney Name: Erin McGeehan Sommers
Defendant Attorneys
13MSN Laboratories
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
MSN Laboratories
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
MSN Pharmaceuticals Inc.
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
MSN Pharmaceuticals Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Reliance Life Sciences Pvt. Ltd.
Attorney Name: Arthur G. Connolly III
Connolly Gallagher LLP
Reliance Life Sciences Pvt. Ltd.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
MSN Laboratories
Attorney Name: Alexander B. Owczarczak
Wiley Rein LLP
MSN Laboratories
Attorney Name: Neal Seth
Wiley Rein LLP
MSN Laboratories
Attorney Name: Teresa Summers
Wiley Rein LLP
MSN Pharmaceuticals Inc.
Attorney Name: Alexander B. Owczarczak
Wiley Rein LLP
MSN Pharmaceuticals Inc.
Attorney Name: Neal Seth
Wiley Rein LLP
MSN Pharmaceuticals Inc.
Attorney Name: Teresa Summers
Wiley Rein LLP
Attorney Name: Neal Seth
Counter Defendant
4H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Counter Claimant
3MSN Laboratories
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10307419 | Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof | Jun 4, 2019 |
| 09839637 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 12, 2017 |
| 08618109 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 31, 2013 |
| 08349840 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jan 8, 2013 |
| 07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |
